{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-018784","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2023-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.664723+00:00","generated_at":"2026-06-14T16:53:06.793483+00:00","sec_items":["1.02","5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Enveric Biosciences cuts 35% of workforce, eliminates President/COO role","bullets":["Announced ~35% reduction in force on May 15, 2023.","Eliminated President and COO positions; Avani Kanubaddi terminated effective June 17, 2023.","Severance includes 12 months base salary continuation and acceleration of unvested RSUs.","Performance bonus for 2023 may be paid if metrics achieved."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-018784","json":"https://secwatch.observer/filing/0001493152-23-018784.json","markdown":"https://secwatch.observer/filing/0001493152-23-018784.md","text":"https://secwatch.observer/filing/0001493152-23-018784.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315223018784/0001493152-23-018784-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315223018784/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T16:53:06.793483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7af0c10d1a","claim":"Avani Kanubaddi was terminated as President and Chief Operating Officer at Enveric Biosciences, Inc..","evidence_excerpt":"the Company terminated the employment contract of Mr. Kanubaddi without Cause (as defined in the Employment Agreement), the President and Chief Operating Officer of the Company, to be effective June 17, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/890821/000149315223018784/0001493152-23-018784-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"President and Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}